Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Deep Vein Thrombosis (DVT): later-stage trial registry
2 of 4 indexed Deep Vein Thrombosis (DVT) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Deep Vein Thrombosis (DVT): 4 US clinical trials tracked, 2 recruiting.
Deep Vein Thrombosis (DVT) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Argon Medical Devices, running 1 of these trials.
Enrollment posture brief
Registry condition deep-vein-thrombosis-dvt
OPEN 2 | RECR 50% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Deep Vein Thrombosis (DVT) lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Deep Vein Thrombosis (DVT) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Deep Vein Thrombosis (DVT) is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Oregon Health and Science University
NCT02342444
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
Argon Medical Devices
NCT07102160
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
NCT02073682
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Alliance Foundation Trials
NCT02744092
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Deep Vein Thrombosis (DVT) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Deep Vein Thrombosis (DVT) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Deep Vein Thrombosis (DVT) page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Deep Vein Thrombosis (DVT) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Argon Medical Devices sponsors the most Deep Vein Thrombosis (DVT) trials on record, review their full trial history before evaluating a specific study. See Argon Medical Devices's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Deep Vein Thrombosis (DVT) condition card totals 4 registered trials; most-linked intervention Edoxaban; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.